Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

Fig. 1

Levels and percentage reactivity of serum antibodies against the different citrullinated fibrinogen (cit-Fib) peptides. Comparison of the levels of antibodies against the four different cit-Fib peptides in serum from patients and controls (a. cit-Fib α35; b. cit-Fib α216;218; c. cit-Fib α263, 271; d. cit-Fib α425, 426). Horizontal dotted line indicates the ELISA cutoff for positivity towards the cit-peptide. Pie charts (bottom) represent the percentage positivity in each cohort. Number of individuals is indicated in the centre of the pie chart. RA rheumatoid arthritis

Back to article page